Key result
IMT-AHF trial evaluates inspiratory muscle training in older patients with acute heart failure.
Why the study?
Evidence regarding the efficacy, safety, and optimal dosing of inspiratory muscle training in older patients with acute heart failure and inspiratory muscle weakness remains limited.
Does high-intensity or low-intensity inspiratory muscle training improve 2-minute walk distance in older patients hospitalized with acute heart failure and inspiratory muscle weakness?
RCT
Multi-arm parallel-group
Does high-intensity or low-intensity inspiratory muscle training improve 2-minute walk distance in older patients hospitalized with acute heart failure and inspiratory muscle weakness?
The IMT-AHF trial is designed to evaluate whether high-intensity inspiratory muscle training improves exercise tolerance in older patients hospitalized with acute heart failure.
IMT lacks evidence in older AHF; this RCT leaves open efficacy and safety for exercise tolerance in inspiratory muscle weakness.
Background: Approximately 70% of older patients with acute heart failure (AHF) exhibit inspiratory muscle weakness (IMW). Inspiratory muscle training (IMT) may improve respiratory function and functional capacity, yet evidence regarding its efficacy, safety, and optimal dosing in this population remains limited. The IMT-AHF trial aims to verify the efficacy and safety of IMT in older patients with AHF.
No takes yet. Share an insight, caveat, or question.
Takahashi et al. (2026) conducted an RCT in Acute heart failure. Inspiratory muscle training (IMT) was evaluated on Efficacy and safety. The IMT-AHF trial is designed to verify the efficacy and safety of inspiratory muscle training in older patients with acute heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: